FDA Approves SYFOVRE™ (pegcetacoplan injection) as the First and Only Treatment for Geographic Atrophy (GA), a Leading Cause of Blindness Read More Feb 17, 2023
ImmPACT Bio Announces FDA Clearance of IND for Novel Bispecific CAR to Treat Aggressive B-cell Lymphoma Read More Feb 3, 2023
Ventyx Biosciences announces pipeline updates and highlights strategic priorities at investor R&D day Read More Jan 23, 2023
NorthSea Therapeutics provides clinical update reflecting progress across NASH and metabolic disorders programmes Read More Jan 5, 2023